XW133B8Transfusion of Betibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8
- Billable / Specific Code
XW133B8 is a billable ICD-10-PCS procedure code for Transfusion of Betibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRGs 016, 017. The root operation Transfusion involves putting in blood or blood products.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | X | New Technology |
| 2 | Body System | W | Anatomical Regions |
| 3 | Operation | 1 | Transfusion |
| 4 | BodyPart | 3 | Peripheral Vein |
| 5 | Approach | 3 | Percutaneous |
| 6 | Device/Substance/Technology | B | Betibeglogene Autotemcel |
| 7 | Qualifier | 8 | New Technology Group 8 |
Code History
- 30233C0 — Transfuse Autol HSPC, Gene Mod in Periph Vein, Perc
Similar Procedure Codes
Questions About XW133B8
Is XW133B8 a billable code?
Yes. XW133B8 is a complete seven-character ICD-10-PCS code, specific enough to report Transfusion of Betibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8 on inpatient claims from October 1, 2025 through September 30, 2026.
What do the characters in XW133B8 mean?
XW133B8 breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character W is the Body System (Anatomical Regions); the 3rd character 1 is the Operation (Transfusion); the 4th character 3 is the BodyPart (Peripheral Vein); the 5th character 3 is the Approach (Percutaneous); the 6th character B is the Device/Substance/Technology (Betibeglogene Autotemcel); the 7th character 8 is the Qualifier (New Technology Group 8).
What MS-DRG does XW133B8 group to?
On an inpatient stay, Transfusion of Betibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8 maps to MS-DRGs 016, 017, with relative weights from 4.8383 to 5.9297. The MS-DRG sets the fixed Medicare payment for the stay.
